Aims This meta-analysis was conducted to evaluate the validity of the Caprini venous
thromboembolism (VTE) risk assessment scale in predicting the risk of VTE in inpatients with …

6598 Background: Quality panels and regulators have focused on inpatient venous
thromboembolism (VTE) as a priority preventable illness. VTE is very prevalent in cancer but …

Venous thromboembolism (VTE) is a commonly encountered problem in patients with
cancer. In recent years, cancer treatment paradigm has shifted with most therapy offered in …

This study aimed to compare the predictive value of 2009 and 2013 version of Caprini risk
assessment models (RAM) for venous thromboembolism (VTE) in cancer patients by …

Background Current guidelines recommend all cancer inpatients receive pharmacologic
VTE prophylaxis in the absence of contraindications. This is extrapolated from trials showing …

Cancer and its treatment are recognized risk factors for VTE. Compliance rate with published
VTE prophylaxis guidelines is low. Decision on when to offer prophylaxis for hospitalized …

Cancer patients with venous thromboembolism (VTE) are prone to poor prognoses. Thus,
we aimed to develop a nomogram to predict the risk of VTE in these patients. We …

This study aimed to identify predictors of venous thromboembolism (VTE) in hospitalized
cancer patients and develop a predictive model using demographic, clinical, and laboratory …

Cancer patients have a high risk of developing venous thromboembolism and arterial
thrombosis, along with an increased risk of anticoagulant-related bleeding with primary and …

Current guidelines recommend that patients with cancer be assessed for venous
thromboembolism (VTE) risk at the time of chemotherapy initiation and periodically …